title: Cabazitaxel for castration-resistant prostate cancer.
authors.forename: Michael
authors.initials: M
authors.lastname: Froehner
authors.forename: Manfred P
authors.initials: MP
authors.lastname: Wirth
mesh_terms: D000726:Androgen Antagonists / Q000008:administration & dosage*; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004334:Drug Administration Schedule; D019008:Drug Resistance, Neoplasm; D006801:Humans; D008297:Male; D008942:Mitoxantrone / Q000008:administration & dosage; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D016019:Survival Analysis; D043823:Taxoids / Q000008:administration & dosage*; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D043823:Taxoids; C552428:cabazitaxel; D008942:Mitoxantrone